Blog Archives

Objective Motion Sensor Assessment Highly Correlated with Scores of Global Levodopa-Induced Dyskinesia in Parkinson’s Disease

T. Mera, M. Burack, J. Giuffrida J Parkinsons Dis. 2013 Jan 1;3(3):399-407.


Effect of unilateral and bilateral STN stimulation and levodopa on distal and proximal alternating movement of the upper limb in Parkinson’s disease

Radics P, Erőss L, Takáts A, Heldman D, Giuffrida J, Entz L, Fabó D, Tamás G International Conference on Deep Brain Stimulation. Dusseldorf, Germany, 2013


Capturing Choreatic Dyskinesia Over Levodopa Dose Cycle in Parkinson’s Disease

T. Mera, Michelle Burack, MD, PhD, Frank Bonsignore, MS, J. Giuffrida, PhD 16th International Congress of Parkinson’s Disease and Movement Disorders, Dublin, Ireland 2012


Capturing Choreatic Dyskinesia Over Levodopa Dose Cycle in Parkinson’s Disease

T. Mera, Michelle Burack, MD, PhD, Frank Bonsignore, MS, J. Giuffrida, PhD American Academy of Neurology 64th Annual Meeting, New Orleans, LA 2012


PRESS RELEASE: The University of Rochester and Great Lakes NeuroTechnologies launch new clinical study to develop ambulatory dyskinesia assessment system

VIEW PRESS RELEASE [PDF] Cleveland, OH – August 15, 2011 – Great Lakes NeuroTechnologies’ KinetiSense motion sensor technology will be used in a clinical study to capture and quantify dyskinesias (involuntary, irregular movements) caused by Parkinson’s disease (PD) medication. PD motor symptoms including tremor and bradykinesia are typically treated with

Read more ›


PRESS RELEASE: Great Lakes NeuroTechnologies’ KinetiSense technology used in Parkinson’s disease gait and balance study

VIEW PRESS RELEASE [PDF] Cleveland, OH – August 15, 2011 – Great Lakes NeuroTechnologies’ KinetiSense motion sensor technology was used in a clinical study to capture and quantify the effect of Deep Brain Stimulation (DBS) on gait and balance impairment in Parkinson’s disease (PD). DBS surgery is typically performed when

Read more ›


Differential Response of Bradykinesia and Hypokinesia to Levodopa in Parkinson’s Disease

A. Espay, J. Giuffrida, Robert Chen, Jennifer E. Vaughan, Andrew P. Duker, D. Heldman Presented at the 2009 World Federation of Neurology World Congress on Parkinson’s Disease and Related Disorders